To include your compound in the COVID-19 Resource Center, submit it here.

Neurocrine Phase III indiplon-IR results

NBIX said that in a double-blind Phase III trial in 593 patients with transient insomnia,

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE